Researchers in the United States have developed a computer program that can simultaneously detect cancer and identify where in the body the cancer is located, from a patient’s blood sample.
The program is described in research published this week in the open access journal Genome Biology.
Professor Jasmine Zhou, co-lead author from the University of California at Los Angeles, said: “Non-invasive diagnosis of cancer is important, as it allows the early diagnosis of cancer, and the earlier the cancer is caught, the higher chance a patient has of beating the disease. We have developed a computer-driven test that can detect cancer, and also identify the type of cancer, from a single blood sample. The technology is in its infancy and requires further validation, but the potential benefits to patients are huge.”
The program works by looking for specific molecular patterns in cancer DNA that is free flowing in the patients’ blood and comparing the patterns against a database of tumour epigenetics, from different cancer types, collated by the authors. DNA from tumour cells is known to end up in the bloodstream in the earliest stages of cancer so offers a unique target for early detection of the disease.
Professor Zhou explained: “We built a database of epigenetic markers, specifically methylation patterns, which are common across many types of cancer and also specific to cancers originating from specific tissue, such as the lung or liver. We also compiled the same ‘molecular footprint’ for non-cancerous samples so we had a baseline footprint to compare the cancer samples against. These markers can be used to deconvolute the DNA found freely in the blood into tumor DNA and non-tumor DNA.”
In this study, the new computer program and two other methods (called Random Forest and Support Vector Machine) were tested with blood samples from 29 liver cancer patients, 12 lung cancer patients and 5 breast cancer patients. Tests were run 10 times on each sample to validate the results. The Random Forest and Support Vector Machine methods had an overall error rate (the chance that the test produces a false positive) of 0.646 and 0.604 respectively, while the new program obtained a lower error rate of 0.265.
Twenty-five out of the 29 liver cancer patients and 5 out of 12 lung cancer patients tested in this study had early stage cancers, which the program was able to detect in 80% of cases. Although the level of tumour DNA present in the blood is much lower during the early stages of these cancers, the program was still able to make a diagnosis demonstrating the potential of this method for the early detection of cancer, according to the researchers.
Professor Zhou added: “Owing to the limited number of blood samples, the results of this study are evaluated only on three cancer types (breast, liver and lung). In general, the higher the fraction of tumor DNAs in blood, the more accurate the program was at producing a diagnostic result. Therefore, tumors in well-circulated organs, such as the liver or lungs are easier to diagnose early using this approach, than in less-circulated organs such as the breast.”
Receive an email update when we add a new CANCER DIAGNOSIS article.
The Latest on: Cancer diagnosis
via Google News
The Latest on: Cancer diagnosis
- Skin Cancer Diagnosis and Therapeutics Market Will Reflect Significant Growth Prospects during 2020 to 2027on February 2, 2020 at 5:52 pm
Ameco Research, Latest Research Report on titled "Global Skin Cancer Diagnosis and Therapeutics Market – Global Industry Analysis, Market Size, Opportunities and Forecast, 2020 - 2027". In the coming ...
- Prostate Cancer Diagnosis and Treatment Market Highlights Key Development Factors and Upcoming Trends During Forecast 2020 to 2027on February 2, 2020 at 5:43 pm
Ameco Research, Latest Research Report on titled "Global Prostate Cancer Diagnosis and Treatment Market – Global Industry Analysis, Market Size, Opportunities and Forecast, 2020 - 2027". In the coming ...
- WWE Hall of Famer Bret Hart Diagnosed With Skin Canceron February 1, 2020 at 10:24 pm
It is most often treated by removing the cancer through surgery. Hart has had several health-related issue in the past. In 2002, he suffered a stroke and was diagnosed with prostate cancer in 2016. A ...
- WWE legend issues public health warning after cancer diagnosison February 1, 2020 at 7:03 am
WWE legend Bret Hart has taken to social media to issue a health warning to his hundreds of thousands of fans after being diagnosed with skin cancer.
- Cronulla youngster Fine Kula retires following brain cancer diagnosison January 31, 2020 at 5:38 pm
The Sharks have confirmed the heart-breaking news that young player Fine Kula has been diagnosed with brain cancer. Kula, 20, has been forced into an immediate retirement and will begin intensive ...
- One of us has been diagnosed with cancer and we're feeling free againon January 31, 2020 at 3:23 pm
Our last move required the equivalent of an 18-wheeler. We’ve both kept detailed calendars and planners for years. The cancer diagnosis has changed almost all of that, focusing us entirely on the here ...
- WWE Legend Bret Hart Reveals Skin Cancer Diagnosison January 31, 2020 at 12:41 pm
Today is an emotional day for wrestling fans as Bret Hart revealed that he has been diagnosed with skin cancer. The legend took to Instagram to tell fans about it himself. Hart has battled with other ...
- WWE Hall of Famer Bret Hart Reveals Skin Cancer Diagnosison January 31, 2020 at 12:19 pm
Basal cell carcinoma is among the most common types of skin cancer and is rarely life-threatening, per WebMD. The 62-year-old Hart has had several health scares over the years. He suffered a stroke in ...
- Lawmaker Whose Wife Just Got Diagnosed with Cancer Announces He Will Miss Impeachment Trialon January 31, 2020 at 10:41 am
Rep. Jerry Nadler, one of Democratic lawmakers prosecuting President Donald Trump‘s impeachment trial in the Senate, announced Friday morning that he would miss the “conclusion” of that case because ...
via Bing News